VERTEX PHARMACEUTICALS (EUROPE) LIMITED (02907620) is a private limited company registered in LONDON, incorporated in 1994. The company operates in the other research and experimental development on natural sciences and engineering sector. Our database holds 87 signals from 10 official sources covering this company's filings, appointments, and regulatory records. The current risk score is 58/100, classified as "stable".
Vertex Pharmaceuticals (Europe) Limited is an active private company incorporated in 1994, located in London, specializing in research and development, with 5 active officers and no active charges.
Good data coverage from 10 sources. Risk score of 58 — no major risk signals detected.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is 1 of 1,105 other research and experimental development on natural sciences and engineering companies in LONDON, out of 5,626 active companies in this sector nationally (6,152 including dissolved).
The 3 directors of VERTEX PHARMACEUTICALS (EUROPE) LIMITED are connected to 3 other companies.
Of these, 1 (33%) are dissolved or failed.
Note: At least one director has a high dissolution ratio (100% of their connected companies have failed).
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is listed as the proprietor of 5 properties in the HM Land Registry.
Properties are located in Greater London, South East.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED pays invoices in an average of 39 days. 20% are paid within 30 days.
This company profile is built from 10 official data sources: Ch Officers, Companies House, Environment Agency, GLEIF, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, ICO, NHS, Payment Practices.
Vertex Pharmaceuticals (Europe) Limited is an active private company incorporated in 1994, located in London, specializing in research and development, with 5 active officers and no active charges..
Current directors include , MR JONATHAN RICHARD OPPENHEIM, and 2 more.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is registered in LONDON, United Kingdom.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED operates under SIC code 72190 — Other research and experimental development on natural sciences and engineering.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED has a risk score of 58 out of 100, classified as "Stable". This score is calculated from 87 data signals across 10 government sources.
The next accounts for VERTEX PHARMACEUTICALS (EUROPE) LIMITED are due on 30 Sept 2026.
Yes, VERTEX PHARMACEUTICALS (EUROPE) LIMITED is listed as the proprietor of 5 properties in the HM Land Registry, located in Greater London, South East.
The dissolution rate for the other research and experimental development on natural sciences and engineering sector in the UK is 0.2%. The average company age in this sector is 10.7 years.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED was incorporated on 11 Mar 1994, making it 32 years old. The company remains active and in good standing.
VERTEX PHARMACEUTICALS (EUROPE) LIMITED is classified under SIC code 72190 (Other research and experimental development on natural sciences and engineering). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 87 data signals from 10 official government sources for VERTEX PHARMACEUTICALS (EUROPE) LIMITED.